Mendelics Análise Genômica
PrivateLast Round
Debt
Apr 10, 2026
Est. Valuation
$120.31M
Total Funding Raised
$22.33M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Mendelics Análise Genômica is a biotechnology company that provides genomic diagnostic services for rare diseases and cancer using next-generation sequencing technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mendelics Análise Genômica Comparables
Compare Mendelics Análise Genômica with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeoGenômica | 80% | |
| CENTOGENE | 78% | |
| Fleury S.A. | 76% |
Mendelics Análise Genômica Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Apr 10, 2026 | ||||
| Series B Extension | Oct 19, 2023 | ||||
| Series B | Nov 26, 2019 | ||||
| Series A | Dec 1, 2014 |
Mendelics Análise Genômica Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Bank for Economic and Social Development | Debt |
| FinHealth Gestão de Recursos | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 10, 2026
$9.55M debt round led by National Bank for Economic and Social Development.
Mendelics Análise Genômica Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mendelics Análise Genômica's valuation, stock price, and market status.
Is Mendelics Análise Genômica a public or private company?
Mendelics Análise Genômica is a private company.
What is the current stock price of Mendelics Análise Genômica?
Mendelics Análise Genômica is a private company with no public stock price. No recent secondary market data is available.
How much is Mendelics Análise Genômica worth (valuation)?
Mendelics Análise Genômica's valuation is estimated at $120.3M based on funding round data.
Can I buy Mendelics Análise Genômica stock?
Mendelics Análise Genômica shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Mendelics Análise Genômica's last funding round?
Mendelics Análise Genômica's most recent funding round was Debt on November 26, 2019.
Who are the main investors in Mendelics Análise Genômica?
Key investors in Mendelics Análise Genômica include National Bank for Economic and Social Development, FinHealth Gestão de Recursos.
Will Mendelics Análise Genômica IPO soon?
No public IPO plans have been announced for Mendelics Análise Genômica.
How can I track Mendelics Análise Genômica secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mendelics Análise Genômica's secondary market activity and sign up for updates.